About Caprienzymes
Caprienzymes is a company based in Chennai (India) founded in 2012 by Vellore Mahendranath Sivaprakasam, Mahalakshmi Vellore Venkatachalam, and Avinnash Sivaprakasam Ravindran. It operates as a B2B. Caprienzymes offers products and services including Aquaculture Feed Supplements, Poultry and Animal Nutrition, Bioremediation Products, Industrial Specialty Bio-Products, and Nutraceuticals for Feed and Food. Caprienzymes operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Chennai, India
- Founders Vellore Mahendranath Sivaprakasam, Mahalakshmi Vellore Venkatachalam, Avinnash Sivaprakasam Ravindran
- SectorsAgriculture
- Email••••••••
- Phone•••• ••••
- Website caprienzymes.com
- Social LinkedIn Instagram
- Legal Name Caprienzymes Technology Private Limited
- Date of Incorporation 28 Sep, 2017
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹9.7 Lakh
FY 2023 · -68% YoY
- Net Profit₹92,250
FY 2023 · 9% margin
- EBITDA₹1.1 Lakh
FY 2023 · 11% margin
Associated legal entities of Caprienzymes
Caprienzymes operates through Caprienzymes Technology Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Caprienzymes Technology Private Limited CIN U93090TN2017PTC118867 | Active | 28 Sep 2017 | Chennai, Tamil Nadu | ₹0.1 Cr | – | 2 | View details |
Products & Services of Caprienzymes
Caprienzymes offers a comprehensive portfolio of products and services, including Aquaculture Feed Supplements, Poultry and Animal Nutrition, Bioremediation Products, Industrial Specialty Bio-Products, and Nutraceuticals for Feed and Food.
Supplements for enhancing aquatic nutrition and health in farming.
Products improving livestock health, digestion, and immunity.
Solutions for waste water treatment and bioremediation processes.
Enzymes for sectors like leather, detergent, and textile processing.
Nutraceuticals enhancing feed and food quality for animals and humans.
Board of directors of Caprienzymes Technology Private Limited (Caprienzymes)
Caprienzymes Technology Private Limited is the primary company behind Caprienzymes. The board of Caprienzymes Technology Private Limited currently have 2 directors; the longest-serving is Mahalakshmi Vellore Venkatachalam, appointed in 2017. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mahalakshmi Vellore Venkatachalam DIN 07906037 | Director | 28 Sep 2017 | 9 yrs | Caprienzymes Technology Private Limited |
| Avinnash Sivaprakasam Ravindran DIN 08571462 | Director | 01 Oct 2019 | 7 yrs | Caprienzymes Technology Private Limited |
People of Caprienzymes
3 people are tracked at Caprienzymes (3 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Caprienzymes
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Caprienzymes
Figures of Caprienzymes Technology Private Limited, the primary company behind Caprienzymes, for FY 2023. Revenue was ₹9.7 Lakh (-68% year on year). Net profit was ₹92,250 (9% margin). EBITDA was ₹1.1 Lakh (11% margin). Revenue has grown at a compounded annual rate of +65% over three years.
- ₹9.7 LakhRevenue · FY 2023 · -68% YoY
- ₹92,250Net profit · 9% margin
- ₹1.1 LakhEBITDA · 11% margin
- ₹1 LakhPaid-up capital
- +65%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Caprienzymes Technology Private Limited are on its company page.
Detailed financial statements for Caprienzymes
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Caprienzymes
Caprienzymes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of Caprienzymes
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Caprienzymes
10 companies that operate in the same segment as Caprienzymes (Aquaculture Feed and Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Feeds for fish and shrimp are manufactured and specialized in. | 1993 | Hyderabad, Telangana, India | – | USD 638.11 M | 1,550 | |
Fully integrated company in aqua feed production, and farming, processing, and supply of shrimp products | 1987 | Chennai, Tamil Nadu, India | – | USD 35.49 M | – | |
Aquaculture feed and nutritional products are produced for the industry. | 1995 | Santiago De Surco, Lima, Peru | – | – | – | |
Specialty marine proteins and nutritional ingredients are produced. | 2014 | Monaghan, Monaghan, Ireland | USD 6.66 M | – | – | |
JOYVIO FOOD was established in 2003 in Shihezi, China. | 2003 | Shihezi, Xinjiang Uyghur Autonomous Region, China | – | USD 468.53 M | – | |
Producing commercial volumes of asparagopsis | 2018 | Hobart, Tasmania, Australia | – | USD 3.43 M | – | |
Develops innovative probiotics, enzymes, and prebiotics for animal health and sustainable aquaculture. | 2002 | Hyderabad, Telangana, India | – | USD 1.55 M | 35 | |
Aquaculture feed and nutritional products are produced by Unique Organics. | 1993 | Jaipur, Rajasthan, India | – | USD 11.19 M | 36 | |
Aquaculture feed and nutrition products are produced and supplied. | 2000 | Samut Sakhon, Thailand | – | USD 190.37 M | – | |
Sustainable aquaculture solutions are developed using mycoproteins by Seaqure Labs. | 2023 | Goteborg, Vastra Gotaland, Sweden | USD 546.67 K | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Caprienzymes
Caprienzymes was founded in 2012.
Caprienzymes is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
The primary company behind Caprienzymes, Caprienzymes Technology Private Limited, reported revenue of ₹9.7 Lakh for FY 2023, down 68% year on year.
Caprienzymes is an Indian biotechnology company that develops enzymes, probiotics, and nutraceuticals for sectors including aquaculture, agriculture, poultry nutrition, bioremediation, and industrial processes. They focus on sustainable practices through innovative products like feed supplements and waste treatment solutions. Based in Chennai, Tamil Nadu, they serve clients such as farmers and manufacturers, ensuring high-quality and environmentally safe offerings certified by standards like GMP.
Caprienzymes's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Caprienzymes offers Aquaculture Feed Supplements, Poultry and Animal Nutrition, Bioremediation Products, Industrial Specialty Bio-Products, and Nutraceuticals for Feed and Food.
Caprienzymes operates through Caprienzymes Technology Private Limited.
The legal entities of Caprienzymes currently have 2 directors, including Avinnash Sivaprakasam Ravindran, Mahalakshmi Vellore Venkatachalam.